Virus Induced Lymphocytes (VIL) as a Novel Viral Antigen-Specific T Cell Therapy for COVID-19 and Potential Future Pandemics

Using a novel SARS-Cov-2-specific artificial antigen presenting cell, coupled with a rapid expansion protocol as practiced in tumor infiltrating lymphocytes therapy, researchers generated an immune catalytic quantity of VIL.